- Home
- SILO vs BNOX Comparison
SILO vs BNOX Comparison
Compare SILO & BNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- BNOX
- Stock Information
- Founded
- SILO 2010
- BNOX 1996
- Country
- SILO United States
- BNOX Australia
- Employees
- SILO N/A
- BNOX N/A
- Industry
- SILO Apparel
- BNOX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SILO Consumer Discretionary
- BNOX Health Care
- Exchange
- SILO Nasdaq
- BNOX Nasdaq
- Market Cap
- SILO 5.9M
- BNOX 7.0M
- IPO Year
- SILO N/A
- BNOX 2021
- Fundamental
- Price
- SILO $1.13
- BNOX $0.29
- Analyst Decision
- SILO
- BNOX Strong Buy
- Analyst Count
- SILO 0
- BNOX 1
- Target Price
- SILO N/A
- BNOX $8.00
- AVG Volume (30 Days)
- SILO 150.8K
- BNOX 29.4M
- Earning Date
- SILO 11-12-2024
- BNOX 01-01-0001
- Dividend Yield
- SILO N/A
- BNOX N/A
- EPS Growth
- SILO N/A
- BNOX N/A
- EPS
- SILO N/A
- BNOX N/A
- Revenue
- SILO $72,102.00
- BNOX N/A
- Revenue This Year
- SILO $1.86
- BNOX N/A
- Revenue Next Year
- SILO N/A
- BNOX N/A
- P/E Ratio
- SILO N/A
- BNOX N/A
- Revenue Growth
- SILO N/A
- BNOX N/A
- 52 Week Low
- SILO $0.84
- BNOX $0.18
- 52 Week High
- SILO $4.50
- BNOX $2.19
- Technical
- Relative Strength Index (RSI)
- SILO 47.77
- BNOX 47.31
- Support Level
- SILO $1.05
- BNOX $0.25
- Resistance Level
- SILO $1.35
- BNOX $0.47
- Average True Range (ATR)
- SILO 0.12
- BNOX 0.08
- MACD
- SILO -0.00
- BNOX 0.01
- Stochastic Oscillator
- SILO 37.14
- BNOX 25.31
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About BNOX Bionomics Limited American Depository Shares
Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.